Point-of-Care Infectious Disease Diagnostics & Testing Market - Global Outlook and Forecast 2023-2027

Report ID: 923593 | Published Date: Oct 2024 | No. of Page: 107 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story

This report contains market size and forecasts of Point-of-Care Infectious Disease Diagnostics & Testing in Global, including the following market information:
Global Point-of-Care Infectious Disease Diagnostics & Testing Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Point-of-Care Infectious Disease Diagnostics & Testing market was valued at 1054.5 million in 2020 and is projected to reach US$ 1289.9 million by 2027, at a CAGR of 5.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Point-of-Care Infectious Disease Diagnostics & Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Point-of-Care Infectious Disease Diagnostics & Testing Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Point-of-Care Infectious Disease Diagnostics & Testing Market Segment Percentages, By Type, 2020 (%)
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
Other Infectious Disease POC

China Point-of-Care Infectious Disease Diagnostics & Testing Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Point-of-Care Infectious Disease Diagnostics & Testing Market Segment Percentages, By Application, 2020 (%)
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others

Global Point-of-Care Infectious Disease Diagnostics & Testing Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Point-of-Care Infectious Disease Diagnostics & Testing Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Point-of-Care Infectious Disease Diagnostics & Testing Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Point-of-Care Infectious Disease Diagnostics & Testing Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Abbott
Thermo Fisher Scientific Inc
Roche
Siemens Healthineers
BD & Company
Chembio Diagnostics Inc.
Trinity Biotech
Cardinal Health
Quest Diagnostics Inc.
Bio-Rad Labs Inc.
bioMérieux SA
Sight Diagnostics Ltd.
Gene POC
Trivitron Healthcare
OJ-Bio Ltd.
Ortho-Clinical Diagnostics

Frequently Asked Questions
Point-of-Care Infectious Disease Diagnostics & Testing Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Point-of-Care Infectious Disease Diagnostics & Testing Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Point-of-Care Infectious Disease Diagnostics & Testing Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports